AGCO
AGCO
$122.30
+0.99%
AGCO Corporation is a global manufacturer of agricultural machinery, producing tractors, combines, hay tools, sprayers, and precision-agriculture technology under its core brands Fendt, Massey Ferguson, and Valtra, with its digital and precision-agronomy initiatives consolidated under the PTx umbrella following a series of acquisitions. The company occupies a top-tier position in the global farm-equipment oligopoly alongside Deere and CNH, distinguished by an unusually heavy revenue and profit skew toward Europe, the Middle East, and Africa (roughly 50-60% of sales and an even larger share of operating profit), while it works to expand its footprint in the larger North and South American markets through a dealer network spanning over 3,000 locations and more than 140 countries. The current investor narrative centers on the tension between AGCO's cyclical end-market exposure — soft global farm income, elevated used-equipment inventories, and cautious dealer ordering — and the margin-accretive potential of its PTx precision-agriculture strategy, which management has framed as a structural growth and mix-improvement story. Recent attention has also focused on the company's exit from its Rabobank retail-financing joint venture in 2026, a move that simplifies the balance sheet and shifts capital allocation priorities, while the stock's sharp one-month rally suggests investors are increasingly positioning for a cyclical inflection in agricultural demand.…
AGCO
AGCO
$122.30
Investment Opinion: Should I buy AGCO Today?
AGCO is rated a Hold with a balanced risk/reward profile. The analyst consensus is 'buy' with a mean recommendation of 2.5, and the average target price of $124.47 implies just 2.8% upside from the current $121.10. The core thesis is that AGCO is a deep-value cyclical play trading at 0.77x sales and 7.85x cash flow, but the near-term upside is limited after a 19.25% one-month rally, and the earnings recovery is not yet confirmed.
The supporting evidence includes: (1) a low price-to-sales ratio of 0.77x versus peers often above 1.5x; (2) a strong ROE of 17.00% and moderate debt-to-equity of 0.63; (3) a forward EPS estimate of $8.90 that, if achieved, would justify a much higher stock price; and (4) a 20.31% relative-strength spread over the past month, indicating positive momentum. However, the operating margin of 6.93% is thin, and the forward PE of 16.25x is above the trailing PE of 10.69x, suggesting the market is not pricing in aggressive growth.
The biggest risks are a prolonged agricultural downturn, European demand weakness, and execution risk on the PTx strategy. The rating would upgrade to Buy if the stock pulls back to the $110-115 range (improving risk/reward) or if forward EPS estimates are revised upward. It would downgrade to Sell if revenue growth turns negative or if operating margins fall below 6%. Relative to its history and peers, AGCO appears undervalued on sales and cash flow, but the discount is warranted by its lower margins and cyclical exposure. The stock is fairly valued at current levels, with asymmetric upside only if the cyclical recovery materializes.
Sign up to view all
AGCO 12-Month Price Forecast
AGCO presents a classic cyclical value opportunity with a strong balance sheet (0.63 debt-to-equity, 17% ROE) and a cheap valuation (0.77x sales), but the near-term upside is limited by thin margins and a modest 2.8% upside to the average analyst target. The recent 19.25% one-month rally suggests the market is pricing in a recovery, yet the 1-year relative strength of -5.30% indicates the stock has lagged the broader market. The key tension is whether the forward EPS of $8.90 is achievable; if it is, the stock could re-rate toward $140-151, but if the agricultural downturn persists, the $98 low is a real risk. I would upgrade to bullish if operating margins show signs of expanding above 8% or if revenue growth turns positive, and downgrade to bearish if forward EPS estimates are revised downward or if the stock breaks below $98.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AGCO's 12-month outlook, with a consensus price target around $124.47 and implied upside of +1.8% versus the current price.
Average Target
$124.47
0 analysts
Implied Upside
+1.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$98 - $151
Analyst target range
AGCO is covered by 15 analysts, a healthy level of institutional interest for a mid-cap industrial, and the consensus recommendation is "buy" with a recommendation mean of 2.5 on what appears to be a 1-to-5 scale (where lower is more bullish), indicating a moderately constructive but not overwhelmingly bullish stance. The average target price of $124.47 implies roughly 2.8% upside from the current $121.10 price, which is a modest expected return and suggests the stock has already rallied close to fair value after its 19.25% one-month surge. The consensus EPS estimate of $8.90 (range of $8.56 to $9.22) and revenue estimate of $11.36 billion (range of $11.03 billion to $11.68 billion) are tightly clustered, indicating high confidence in the near-term earnings outlook even if the target prices show wider dispersion. The narrow upside to the average target, combined with the recent sharp price appreciation, implies the market has largely priced in the analysts' base-case scenario and that further gains will require either estimate revisions upward or multiple expansion. The target range spans $98.00 to $151.00, a wide 54% spread from low to high that signals meaningful disagreement about AGCO's trajectory. The high target of $151 assumes a successful cyclical recovery, PTx-driven margin expansion toward peer levels, and multiple re-rating — essentially a best-case scenario where the precision-agriculture strategy transforms AGCO's growth and profitability profile. The low target of $98 is essentially the 52-week low and prices in a continuation of the farm-equipment downturn, margin compression, and European demand weakness, effectively assuming no re-rating and trough earnings. The fact that the average target sits just 2.8% above the current price, while the stock has already rallied 19% in a month, suggests analysts may be lagging the price action and could revise targets upward if the momentum persists — or, alternatively, that the rally has overshot fundamentals and a pullback toward the $110-115 zone is plausible. With no institutional ratings upgrade/downgrade history available in the data, the signal strength is moderate: the wide target spread and the modest average upside argue for caution, but the buy consensus and the stock's strong relative strength suggest the balance of evidence still favors the bulls.
Drowning in data?
Find the real signal!
Bulls vs Bears: AGCO Investment Factors
The bull case rests on deep value (0.77x sales, 7.85x cash flow), a strong balance sheet (0.63 debt-to-equity, 17% ROE), and the optionality of the PTx precision-agriculture strategy, supported by a 'buy' consensus and recent momentum (+19.25% in one month). The bear case emphasizes thin margins (6.93% operating), European concentration (50-60% of sales), cyclical headwinds, and the modest 2.8% upside to the average analyst target. Currently, the bulls have stronger evidence: the stock is cheap on multiple metrics, the balance sheet is healthy, and the recent relative-strength surge suggests a potential inflection. The single most important tension is whether the cyclical recovery in farm income materializes to convert the depressed trailing earnings into the forecasted $8.90 EPS; if it does, the stock could re-rate toward the $151 high target, but if the downturn persists, the $98 low remains a real risk.
Bullish
- Deep Value on Sales and Cash Flow: AGCO trades at just 0.77x trailing sales and 7.85x price-to-cash-flow, both well below typical industrial machinery multiples. With a market cap of $7.94 billion against $11.36 billion in forward revenue, the market is pricing in a severe cyclical trough despite the company's top-tier global position.
- Strong Balance Sheet and ROE: Debt-to-equity of 0.63 is moderate, the current ratio of 1.39 indicates solid liquidity, and ROE of 17.00% is robust for a capital-intensive manufacturer. These metrics suggest AGCO can fund its PTx precision-agriculture transition internally without straining its financial position.
- Analyst Consensus Buy with Upside: 15 analysts rate the stock a 'buy' with a mean recommendation of 2.5, and the average target price of $124.47 implies 2.8% upside from the current $121.10. The high target of $151.00 represents 24.7% upside and reflects optimism about a cyclical recovery and margin expansion.
- Recent Momentum and Relative Strength: AGCO has surged 19.25% over the past month versus a -1.06% decline in SPY, producing a 20.31% relative-strength spread. This sharp outperformance, combined with a 14.42% YTD gain, suggests a genuine re-rating driven by stock-specific catalysts rather than a broad market move.
Bearish
- Thin Margins and Depressed Earnings: Net margin of 7.21% and operating margin of 6.93% are thin, and trailing EPS of just $0.09 is a fraction of the $8.90 forward estimate. This massive gap signals that the trailing figure is distorted by one-time charges or trough conditions, and the recovery is far from guaranteed.
- European Concentration Risk: AGCO derives 50-60% of sales and an even larger share of operating profits from Europe/Middle East, exposing it to regional economic weakness, currency fluctuations, and geopolitical risks. This concentration is a key reason the stock trades at a discount to more geographically balanced peers like Deere.
- Modest Analyst Upside and Wide Target Spread: The average target of $124.47 offers only 2.8% upside, suggesting the stock has already rallied to fair value. The target range spans $98 to $151, a 54% spread that signals significant disagreement about AGCO's trajectory and limited near-term conviction.
- Cyclical End-Market Headwinds: Soft global farm income, elevated used-equipment inventories, and cautious dealer ordering continue to pressure demand. The 29.92% maximum drawdown over the past year underscores how violently the stock can swing with the agricultural cycle, and a downturn could push shares back toward the $98 low.
AGCO Technical Analysis
AGCO is in a choppy, range-bound recovery rather than a clean trend, with the shares up 10.92% over the trailing twelve months but still 15.8% below the 52-week high of $143.78 and 23.3% above the 52-week low of $98.22, placing the current $121.10 price at roughly 50% of its 52-week range. That mid-range positioning is consistent with a market that has neither fully embraced a cyclical upswing nor capitulated to a downturn, and the 29.92% maximum drawdown over the period underscores how violently the stock has swung between those poles. The 1-year relative strength versus the S&P 500 of -5.30% confirms AGCO has lagged the broader market despite its positive absolute return, meaning the recovery has been real but incomplete. Recent momentum has been decisively positive: the stock is up 19.25% over the past month versus a -1.06% decline in SPY, producing a striking 20.31% relative-strength spread, while the 3-month gain of 7.65% and 6-month gain of 2.13% show a clear acceleration in the pace of gains. This one-month surge diverges sharply from the more muted 1-year trend and the negative 6-month relative strength of -13.27%, a pattern that typically signals either the early stage of a trend reversal or an oversold bounce that could fade — the fact that the move is accompanied by a 14.42% YTD gain and a 2.34% YTD relative-strength edge leans toward genuine re-rating rather than a dead-cat bounce. The stock's beta of 1.095 indicates it moves roughly 10% more than the market, so the recent 19% monthly move is meaningfully larger than what beta alone would predict, implying stock-specific catalysts are at work. Technically, the $98.22 52-week low is the critical support zone, and the August 18 close of $98.45 marked a successful retest of that floor before the sharp rally; resistance sits at the $143.78 52-week high, with intermediate resistance around the late-July high of $123.71 and the $133.40 spike on September 4. A breakout above $133-144 would confirm a new uptrend and likely draw momentum buyers, while a breakdown below $98 would signal that the August bounce failed and expose the stock to a deeper cyclical de-rating; with a short ratio of 3.69, there is also a modest short base that could amplify upside on a breakout.
Beta
1.09
1.09x market volatility
Max Drawdown
-29.9%
Largest decline past year
52-Week Range
$98-$144
Price range past year
Annual Return
+12.2%
Cumulative gain past year
| Period | AGCO Return | S&P 500 |
|---|---|---|
| 1m | +20.7% | -2.0% |
| 3m | +8.0% | +1.4% |
| 6m | +8.7% | +15.0% |
| 1y | +12.2% | +15.7% |
| ytd | +15.6% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AGCO Fundamental Analysis
AGCO's revenue trajectory is best characterized as cyclically pressured but stabilizing, with consensus estimates pointing to roughly $11.36 billion in forward revenue (range of $11.03 billion to $11.68 billion) against a market cap of $7.94 billion, implying a price-to-sales ratio of just 0.77x. The company's net margin of 7.21% and operating margin of 6.93% indicate that profitability is thin relative to the revenue base, consistent with a capital-intensive machinery manufacturer operating below mid-cycle volumes. With trailing EPS of just $0.09 against forward EPS estimates of $8.90, the data imply a dramatic earnings recovery is expected — a roughly 95-fold increase — which is almost certainly an artifact of a depressed trailing figure (possibly reflecting restructuring, JV-exit charges, or a trough earnings quarter) rather than a literal forecast, but it nonetheless signals that the market expects a sharp cyclical rebound in farm-equipment demand and margin normalization. The gross margin of 24.75% is respectable for the industry but leaves limited cushion, and the payout ratio of 11.91% on a 1.11% dividend yield suggests management is retaining the vast majority of earnings to fund the PTx transition and balance-sheet priorities. On the balance sheet, AGCO looks reasonably healthy: debt-to-equity of 0.63 is moderate for an industrial, the current ratio of 1.39 indicates adequate short-term liquidity, and ROE of 17.00% is strong relative to the 3.47% ROA, reflecting meaningful financial leverage. The price-to-cash-flow ratio of 7.85x implies the business is generating substantial operating cash flow relative to its equity value, which supports the view that AGCO can fund its precision-agriculture investments internally rather than relying on external financing. However, the negative PEG ratio of -0.04 is a red flag that reflects the distorted trailing earnings base and makes the PEG metric unusable for valuation purposes; investors should focus on the forward earnings recovery and cash-generation capacity instead. Overall, the financial risk profile is moderate — not distressed, but not fortress-like — and the investment case hinges on whether the cyclical recovery in farm income materializes to convert the depressed trailing earnings into the forecasted forward profitability.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AGCO Overvalued?
Because AGCO's trailing net income is positive (net margin of 7.21% on a $7.94 billion market cap), the PE ratio is the appropriate primary metric, and the stock trades at a trailing PE of 10.69x versus a forward PE of 16.25x — an unusual inversion where the forward multiple exceeds the trailing multiple. This inversion implies the market expects earnings to decline from the trailing base, or more likely that the trailing EPS figure is distorted by one-time items and the forward estimate of $8.90 reflects a normalized but lower earnings power than the trailing number suggests; either way, the gap signals that the market is not pricing in aggressive growth and is instead valuing AGCO on mid-cycle earnings. Relative to the broader Industrials sector, a trailing PE of 10.69x and EV/EBITDA of 9.62x are modest, and the price-to-sales of 0.77x and EV/sales of 1.08x are low on an absolute basis, suggesting the stock trades at a discount to the market and likely to large-cap machinery peers such as Deere, which typically command mid-teens to low-twenties earnings multiples. The price-to-book of 1.82x is also undemanding for a company with a 17.00% ROE, implying the market is skeptical about the durability of those returns. On a peer-relative basis, AGCO's 0.77x sales multiple versus an industry where premium agricultural equipment names often trade above 1.5x sales represents a substantial discount, which could be justified by AGCO's lower margins (6.93% operating vs. peers' low-to-mid teens), its European concentration risk, and its smaller scale — but it also leaves room for multiple expansion if the PTx strategy lifts margins toward peer levels. Historical ratio data is not available in the provided inputs, so a precise assessment of where the current 10.69x trailing PE sits within AGCO's own historical band cannot be made; however, the combination of a sub-1x sales multiple, a 1.82x book multiple, and a 7.85x price-to-cash-flow ratio collectively suggests the stock is valued toward the lower end of its historical range, consistent with a cyclical trough valuation that offers asymmetric upside if earnings normalize but limited downside protection if the downturn persists.
PE
10.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.6x
Enterprise Value Multiple
Investment Risk Disclosure
AGCO's financial risk profile is moderate but not fortress-like. The company carries a debt-to-equity of 0.63, which is manageable for an industrial, but its thin operating margin of 6.93% leaves little cushion if demand weakens further. The massive gap between trailing EPS of $0.09 and forward EPS of $8.90 signals that the trailing figure is distorted by one-time items or trough conditions, and any delay in the earnings recovery could pressure the stock. Additionally, the payout ratio of 11.91% on a 1.11% dividend yield indicates that management is retaining most earnings to fund the PTx transition, limiting shareholder returns in the near term.
Market and competitive risks are significant. AGCO trades at a trailing PE of 10.69x and 0.77x sales, a discount to peers like Deere, but this discount is justified by its lower margins and European concentration (50-60% of sales). If the agricultural downturn persists, the stock could face further multiple compression. The beta of 1.095 means AGCO is slightly more volatile than the market, and the 29.92% maximum drawdown over the past year highlights its sensitivity to cyclical swings. Regulatory risks in Europe, such as emissions standards or trade policies, could also impact demand. The recent 19.25% one-month rally may have overshot fundamentals, and a pullback toward the $110-115 zone is plausible if momentum fades.
The worst-case scenario would be a continuation of the farm-equipment downturn, driven by weak crop prices, high used-equipment inventories, and a European recession. In this scenario, AGCO's earnings could fail to recover, and the stock could retest its 52-week low of $98.22, representing a 18.9% decline from the current $121.10. The analyst low target of $98.00 aligns with this level, and a breakdown below $98 would signal a deeper cyclical de-rating. Investors could lose approximately 19% from the current price in this adverse scenario, with further downside if the PTx strategy fails to gain traction.
FAQ
The biggest risk is a prolonged agricultural downturn, which could push earnings below expectations and drive the stock toward its 52-week low of $98.22. European concentration (50-60% of sales) exposes AGCO to regional economic weakness and currency fluctuations. Thin operating margins of 6.93% leave little cushion for error, and the PTx strategy may not deliver the expected margin expansion. Finally, the stock's beta of 1.095 and 29.92% maximum drawdown highlight its volatility, making it unsuitable for risk-averse investors.
The 12-month forecast is neutral with a base case target range of $115-130 (55% probability), reflecting a slow recovery and fair valuation. The bull case targets $140-151 (25% probability) if farm income rebounds and PTx drives margin expansion. The bear case targets $98-110 (20% probability) if the downturn persists. The most likely scenario is the base case, assuming EPS meets the $8.90 consensus and revenue stabilizes around $11.36 billion. The average analyst target of $124.47 aligns with the base case.
AGCO appears undervalued on most metrics. It trades at 0.77x sales and 7.85x cash flow, compared to peers like Deere that often command above 1.5x sales. The trailing PE of 10.69x is low, though the forward PE of 16.25x suggests the market expects earnings to decline from the trailing base. The price-to-book of 1.82x is also undemanding for a 17% ROE. The discount is justified by AGCO's lower margins (6.93% operating) and European concentration, but it leaves room for multiple expansion if the PTx strategy lifts profitability.
AGCO is a good buy for value-oriented investors with a long-term horizon, but it carries cyclical risk. The stock trades at a trailing PE of 10.69x and 0.77x sales, well below peers, and offers a 2.8% upside to the average analyst target of $124.47. However, the recent 19.25% one-month rally has reduced the near-term margin of safety, and the 18.9% downside to the 52-week low of $98.22 is a real risk if the agricultural downturn persists. For those willing to wait for a cyclical recovery, the risk/reward is favorable, but it is not a short-term trade.
AGCO is better suited for long-term investment (2-3 years) to ride out the agricultural cycle. The stock is volatile (beta 1.095) and has a low dividend yield of 1.11%, so it does not offer income. Short-term trading is risky given the 29.92% maximum drawdown and the recent 19.25% rally that may be due for a pullback. Long-term investors can benefit from the cyclical recovery and the PTx strategy, but they must tolerate interim volatility. A minimum holding period of 2 years is recommended to capture the full cycle.
